References

  1. Global tuberculosis report 2023. Geneva: World Health Organization; 2023 (https://iris.who.int/handle/10665/373828, accessed 8 November 2023).
  2. Gupta RK, Lucas SB, Fielding KL, Lawn SD. Prevalence of tuberculosis in post-mortem studies of HIVinfected adults and children in resource-limited settings: a systematic review and meta-analysis. AIDS. 2015;29(15):1987–2002. doi: 10.1097/QAD.0000000000000802.
  3. The End TB Strategy. Geneva: World Health Organization; 2014 (https://apps.who.int/iris/handle/10665/331326, accessed 19 Aug 2023).
  4. Political Declaration on the High-Level Meeting on the Fight Against Tuberculosis “Advancing science, finance and innovation, and their benefits, to urgently end the global tuberculosis epidemic, in particular by ensuring equitable access to prevention, testing, treatment and care”. New York: United Nations; 2023 (https:// documents-dds-ny.un.org/doc/UNDOC/GEN/N23/306/91/PDF/N2330691.pdf, accessed 17 January 2024).
  5. Political Declaration on HIV and AIDS: Ending Inequalities and Getting on Track to End AIDS by 2030. Geneva: United Nations; 2021 (https://www.unaids.org/sites/default/files/media_asset/2021_political-declaration-onhiv-and-aids_en.pdf, accessed 31 August 2023).
  6. Interim policy on collaborative TB/HIV activities. Geneva: World Health Organization; 2004 (https://apps.who.int/iris/handle/10665/78705, accessed 31 August 2023).
  7. WHO policy on collaborative TB/HIV activities: guidelines for national programmes and other stakeholders. Geneva: World Health Organization; 2012 (https://apps.who.int/iris/handle/10665/44789, accessed 31 August 2023).
  8. WHO consolidated guidelines on tuberculosis. Module 5: management of tuberculosis in children and adolescents. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/handle/10665/352522, accessed 31 August 2023).
  9. WHO consolidated guidelines on tuberculosis. Module 1: prevention – tuberculosis preventive treatment. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/handle/10665/331170, accessed 31 August 2023).
  10. WHO consolidated guidelines on tuberculosis Module 4: treatment – drug-resistant tuberculosis treatment, 2022 update. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/handle/10665/365308, accessed 31 August 2023).
  11. WHO consolidated guidelines on tuberculosis Module 2: screening – systematic screening for tuberculosis disease. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/handle/10665/340255, accessed 31 August 2023).
  12. WHO consolidated guidelines on tuberculosis. Module 3: diagnosis – rapid diagnostics for tuberculosis detection, 2021 update. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/handle/10665/342331, accessed 31 August 2023).
  13. WHO consolidated guidelines on tuberculosis. Module 3: diagnosis – tests for tuberculosis infection. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/handle/10665/362936, accessed 21 August 2023).
  14. WHO consolidated guidelines on tuberculosis. Module 4: treatment – drug-susceptible tuberculosis treatment. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/handle/10665/353829, accessed 31 August 2023).
  15. WHO consolidated guidelines on tuberculosis. Module 4: treatment – tuberculosis care and support. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/handle/10665/353399, accessed 31 August 2023).
  16. Guidelines for diagnosing and managing disseminated histoplasmosis among people living with HIV. Washington, D.C.: Pan American Health Organization, World Health Organization; 2020 (https://iris.paho.org/bitstream/handle/10665.2/52304/9789275122495_eng.pdf, accessed 31 August 2023).
  17. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach, 2021 update. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/handle/10665/342899, accessed 31 August 2023).
  18. Guidance for national tuberculosis programmes on the management of tuberculosis in children, 2nd ed. Geneva: World Health Organization; 2014 (https://apps.who.int/iris/handle/10665/112360, accessed 31 August 2023).
  19. Consolidated guidelines on HIV testing services, 2019. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/handle/10665/336323, accessed 31 August 2023).
  20. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy, July 2017. Geneva: World Health Organization; 2017 (https://apps.who.int/iris/handle/10665/255884, accessed 31 August 2023).
  21. Guidelines: updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/handle/10665/340190, accessed 31 August 2023).
  22. Framework for collaborative action on tuberculosis and comorbidities. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/handle/10665/361989, accessed 31 August 2023).
  23. Eang MT, Vun MC, Eam KK, Sovannarith S, Sopheap S, Bora N et al. The multi-step process of building TB/HIV collaboration in Cambodia. Health Res Policy and Syst. 2012;10:34. doi: 10.1186/1478-4505-10-34.
  24. Okot-Chono R, Mugisha F, Adatu F, Madraa E, Dlodlo R, Fujiwara P. Health system barriers affecting the implementation of collaborative TB–HIV services in Uganda. Int J Tuberc Lung Dis. 2009;13:955-61. PMID: 19723374.
  25. Multisectoral accountability framework to accelerate progress to end tuberculosis by 2030. Geneva: World Health Organization; 2019 (https://apps.who.int/iris/handle/10665/331934, accessed 31 August 2023).
  26. Tuberculosis prevalence surveys: a handbook. Geneva: World Health Organization; 2011 (https://apps.who.int/iris/handle/10665/44481, accessed 31 August 2023).
  27. Guidance for the surveillance of drug resistance in tuberculosis, 6th ed. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/handle/10665/339760, accessed 31 August 2023).
  28. WHO consolidated guidelines on tuberculosis data generation and use. Module 3: national tuberculosis prevalence surveys, World Health Organization, in press, 2024.
  29. Mitchell EMH, van den Broek J, Wandwalo E, Colvin C. Lessons from loss: A guide to conducting TB patient mortality audits using a patient-centered approach. The Hague: KNCV Tuberculosis Foundation TB CARE I; 2012 (https://www.challengetb.org/publications/tools/hss/Lessons_from_Loss.pdf, accessed 27 January 2023).
  30. Strategizing national health in the 21st century: a handbook. Geneva: World Health Organization; 2016 (https://apps.who.int/iris/handle/10665/250221, accessed 31 August 2023).
  31. Harmonized health facility assessment (HHFA): comprehensive guide. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/handle/10665/365534, accessed 31 August 2023).
  32. Guide to develop a national action plan on public-private mix for tuberculosis prevention and care. Geneva: World Health Organization; 2017 (https://apps.who.int/iris/handle/10665/361884, accessed 31 August 2023).
  33. People-centred framework for tuberculosis programme planning and prioritization: user guide. Geneva: World Health Organization; 2019 (https://apps.who.int/iris/handle/10665/329472, accessed 31 August 2023).
  34. WHO operational handbook on tuberculosis. Module 4: treatment – tuberculosis care and support. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/handle/10665/359147, accessed 31 August 2023).
  35. Siddiqi K, Keding A, Marshall A-M, Dogar O, Li J, Huque R et al. Effect of quitting smoking on health outcomes during treatment for tuberculosis: secondary analysis of the TB & Tobacco Trial. Thorax. 2022;77(1):74–78. doi: 10.1136/THORAXJNL-2020-215926.
  36. Pasha A, Siddiqui H, Ali S, Brooks MB, Maqbool NR, Khan AJ. Impact of integrating mental health services within existing tuberculosis treatment facilities. Med Access Point Care. 2021;5. doi: 10.1177/23992026211011314.
  37. Gilbert JA, Shenoi SV, Moll AP, Friedland GH, Paltiel AD, Galvani AP. Cost-effectiveness of community-based TB/HIV screening and linkage to care in rural South Africa. PLoS One. 2016;11(12):e0165614. doi: 10.1371/ journal.pone.0165614.
  38. Williams AO, Makinde OA, Ojo M. Community-based management versus traditional hospitalization in treatment of drug-resistant tuberculosis: a systematic review and meta-analysis. Glob Health Res Policy. 2016;1(10). doi: 10.1186/S41256-016-0010-Y.
  39. Accessibility and integration of HIV, TB and harm reduction services for people who inject drugs in Portugal: a rapid assessment. Copenhagen: World Health Organization Regional Office for Europe; 2012 (https://researchonline.lshtm.ac.uk/id/eprint/1805470, accessed 31 August 2023).
  40. Country case studies on primary health care: China: multidisciplinary teams and integrated service delivery across levels of care. Geneva: World Health Organization; 2018 (https://apps.who.int/iris/handle/10665/326085, accessed 31 August 2023).
  41. Legido-Quigley H, Montgomery CM, Khan P, Atun R, Fakoya A, Getahun H et al. Integrating tuberculosis and HIV services in low- and middle-income countries: a systematic review. Trop Med Int Health. 2013;18(2):199– 211. doi: 10.1111/tmi.12029.
  42. Herce ME, Morse J, Luhanga D, Harris J, Smith HJ, Besa S et al. Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study. BMC Infect Dis. 2018;18(536). doi: 10.1186/S12879-018-3392-2.
  43. Burnett SM, Zawedde-Muyanja S, Hermans SM, Weaver MR, Colebunders R, Manabe YC. Effect of TB/ HIV integration on TB and HIV indicators in rural Ugandan health facilities. Acquir Immune Defic Syndr. 2018;79(5):605–11. doi: 10.1097/QAI.0000000000001862.
  44. Brown C, Kerschberger B, Boulle A, Cotzee D, Post F, Azevedo V. TB and HIV service integration within a South African primary health care setting reduces the time to ART initiation without negatively impacting TB outcomes. In: Proceedings. 18th Conference on Retroviruses and Opportunistic Infections (CROI 2011), 27 February–2 March 2011, Boston.
  45. Bygrave H, Trivino L, Makakole L. TB/HIV integration: lessons learned from implementation of a TB/HIV “one stop shop” at primary health care clinics in rural Lesotho. In: Proceedings. XVIII International AIDS Conference, Vienna, 2010.
  46. Management of collaborative TB/HIV activities: training for managers at the national and subnational levels. Geneva: World Health Organization; 2005 (https://apps.who.int/iris/handle/10665/69374, accessed 31 August 2023).
  47. WHO guideline on health policy and system support to optimize community health worker programmes. Geneva: World Health Organization; 2018 (https://apps.who.int/iris/handle/10665/275474, accessed 31 August 2023).
  48. Datiko DG, Lindtjørn B. Health extension workers improve tuberculosis case detection and treatment success in southern Ethiopia: a community randomized trial. PLoS One. 2009;4(5):e5443. doi: 10.1371/journal. pone.0005443.
  49. Corbett EL, Bandason T, Duong T, Dauya E, Makamure B, Churchyard GJ et al. Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial. Lancet. 2010;376(9748):1244–53. doi: 10.1016/S0140-6736(10)61425-0.
  50. Lugada E, Levin J, Abang B, Mermin J, Mugalanzi E, Namara G et al. Comparison of home and clinic-based HIV testing among household members of persons taking antiretroviral therapy in Uganda: results from a randomized trial. J Acquir Immune Defic Syndr. 2010;55(2):245–52. doi: 10.1097/QAI.0b013e3181e9e069.
  51. Miti S, Mfungwe V, Reijer P, Maher D. Integration of tuberculosis treatment in a community-based home care programme for persons living with HIV/AIDS in Ndola, Zambia. Int J Tuberc Lung Dis. 2003;7(9 Suppl 1):S92–8. PMID: 12971660.
  52. Wandwalo E, Kapalata N, Tarimo E, Corrigan CB, Morkve O. Collaboration between the national tuberculosis programme and a non governmental organisation in TB/HIV care at a district level: experience from Tanzania. Afr Health Sci. 2004;4(2):109–114. PMID: 15477189.
  53. Lindsay BR, Mwango L, Toeque M-G, Malupande SL, Nkhuwa E, Moonga CN et al. Peer community health workers improve HIV testing and ART linkage among key populations in Zambia: retrospective observational results from the Z-CHECK project, 2019–2020. J Int AIDS Soc. 2022;25(11):e26030. doi: 10.1002/JIA2.26030.
  54. Sinanovic E, Floyd K, Dudley L, Azevedo V, Grant R, Maher D. Cost and cost-effectiveness of communitybased care for tuberculosis in Cape Town, South Africa. Int J Tuberc Lung Dis. 2003;7:S56–62. PMID: 12971655
  55. Okello D, Floyd K, Adatu F, Odeke R, Gargioni G. Cost and cost-effectiveness of community-based care for tuberculosis patients in rural Uganda. Int J Tuberc Lung Dis. 2003;7(9 Suppl 1). PMID: 12971657.
  56. Creese A, Floyd K, Alban A, Guinness L. Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. Lancet. 2002;359(9318):1635–42. doi: 10.1016/S0140-6736(02)08595-1.
  57. Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. Geneva: World Health Organization; 2022. (https://apps.who.int/iris/handle/10665/360601, accessed 31 August 2023).
  58. Getahun H, Baddeley A, Raviglione M. Managing tuberculosis in people who use and inject illicit drugs. Bull World Health Organ. 2013;91(2):154. doi: 10.2471/BLT.13.117267.
  59. Dolan K, Wirtz AL, Moazen B, Ndeffo-mbah M, Galvani A, Kinner SA et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. 2016;388(10049):1089–102. doi: 10.1016/ S0140-6736(16)30466-4.
  60. Salifu RS, Hlongwana KW. Barriers and facilitators to bidirectional screening of TB-DM in Ghana: healthcare workers’ perspectives. PLoS One. 2020;15(7). doi: 10.1371/journal.pone.0235914.
  61. Contreras CC, Millones AK, Cruz JS, Aguilar M, Clendenes M, Toranzo M et al. Addressing tuberculosis patients’ medical and socio-economic needs: a comprehensive programmatic approach. Trop Med Int Health. 2017;22(4):505–11. doi: 10.1111/TMI.12844.
  62. Degefa MG, Bezabih AM, Kahsay ZH, Belachew AB. Barriers and facilitators of nutrition assessment, counseling, and support for tuberculosis patients: a qualitative study. BMC Nutr. 2021;7(1):58. doi: 10.1186/ s40795-021-00463-x.
  63. Tanimura T, Jaramillo E, Weil D, Raviglione M, Lönnroth K. Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review. Eur Respir J. 2014;43(6):1763–75. doi: 10.1183/09031936.00193413.
  64. World Health Organization: Preventing TB: [website]. (https://www.who.int/activities/preventing-tb#app, accessed 31 August 2023).
  65. A guide to monitoring and evaluation for collaborative TB/HIV activities – 2015 revision. Geneva: World Health Organization; 2015 (https://apps.who.int/iris/handle/10665/150627, accessed 31 August 2023).
  66. Consolidated HIV strategic information guidelines: driving impact through programme monitoring and management. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/handle/10665/331697, accessed 31 August 2023).
  67. Operational framework for primary health care: transforming vision into action. Geneva: World Health Organization, United Nations Children’s Fund (UNICEF); 2020 (https://apps.who.int/iris/handle/10665/337641, accessed 31 August 2023).
  68. Continuity and coordination of care: a practice brief to support implementation of the WHO Framework on integrated people-centred health services. Geneva: World Health Organization; 2018 (https://apps.who.int/iris/handle/10665/274628, accessed 31 August 2023).
  69. Handbook for the use of digital technologies to support tuberculosis medication adherence. Geneva: World Health Organization; 2017 (https://apps.who.int/iris/handle/10665/259832, accessed 31 August 2023).
  70. University of Oslo, UiO: HISP Centre, DHIS2 [website] (https://dhis2.org, accessed 31 August 2023).
  71. Ethics guidance for the implementation of the End TB strategy. Geneva: World Health Organization; 2017 (https://iris.who.int/handle/10665/254820, accessed 31 August 2023).
  72. Sculier D, Getahun H, Lienhardt C. Improving the prevention, diagnosis and treatment of TB among people living with HIV: the role of operational research. J Int AIDS Soc. 2011;14(Suppl 1):S5S. doi: 10.1186/1758- 2652-14-S1-S5.
  73. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva: World Health Organization; 2011 (https://iris.who.int/handle/10665/44472, accessed 31 August 2023).
  74. Bjerrum S, Bonsu F, Hanson-Nortey NN, Kenu E, Johansen IS, Andersen AB et al. Tuberculosis screening in patients with HIV: use of audit and feedback to improve quality of care in Ghana. Glob Health Action. 2016;9:32390. doi: 10.3402/gha.v9.32390.
  75. Der JB, Grint DJ, Narh CT, Bonsu F, Grant AD. Missed opportunities for tuberculosis investigation in a municipal hospital in Ghana: evidence from patient exit interviews. Trans R Soc Trop Med Hyg. 2021;115(1):43–50. doi: 10.1093/trstmh/traa080.

Book navigation